About this document

Amneal Pharmaceuticals: Growth Strategy Insights by singhut449 is a document available to read on EtoBox.

Amneal Pharmaceuticals (AMRX) aims to become a top-5 global player in biosimilars over the next 5-7 years, highlighting significant market opportunities with only ~20% of upcoming biologics having biosimilars in development. The company is also focusing on the GLP-1 market through its MTSR partnership, targeting emerging markets and contract manufacturing opportunities, while its specialty segment is expected to grow with the launch of Crexont for Parkinson

Author

singhut449

Language

EN